# Delivery Order #SPE2DP26F8307

Naloxone Hydrochloride Delivery Order for Federal Pharmaceutical Supply

**Buyer:** Defense Logistics Agency

**Award Amount:** $1,621.00
**Ceiling:** $1,621.00

**Awarded:** July 27, 2026
**Period of Performance:** Jul 27, 2026 - Aug 11, 2026

**Identifier:** SPE2DP26F8307
**NAICS:** 424210

This is a delivery order under DMS Pharmaceutical Group Inc.’s long-term pharmaceutical supply contract with the federal government. DMS is a pharmaceutical distributor supplying medicines for federal health needs. The order covers naloxone hydrochloride, a medication used to reverse opioid overdoses; the available record does not specify its formulation, quantity, or other delivery details. It supports access to an important emergency treatment through the broader federal pharmaceutical supply arrangement. The parent contract is a multi-year vehicle established in 2025 and expected to continue through 2038. The order was issued for a brief performance period in 2026. The data does not identify whether this order was competed or sole-source, an acquisition program, subcontractors, prior related orders, or an original solicitation.

### Description

8512264074!NALOXONE HYDROCHLOR

[View original record](https://www.usaspending.gov/award/CONT_AWD_SPE2DP26F8307_9700_SPE2DX25D9900_9700)